Class 1 integron-borne cassettes harboring blaCARB-2 gene in multidrug-resistant and virulent Salmonella Typhimurium ST19 strains recovered from clinical human stool samples, United States.

International lineages, such as Salmonella Typhimurium sequence type (ST) 19, are most often associated with foodborne diseases and deaths in humans. In this study, we compared the whole-genome sequences of five S. Typhimurium strains belonging to ST19 recovered from clinical human stool samples in North Carolina, United States. Overall, S. Typhimurium strains displayed multidrug-resistant profile, being resistance to critically and highly important antimicrobials including ampicillin, ticarcillin/clavulanic acid, streptomycin and sulfisoxazole, chloramphenicol, tetracycline, respectively. Interestingly, all S. Typhimurium strains carried class 1 integron (intl1) and we were able to describe two genomic regions surrounding blaCARB-2 gene, size 4,062 bp and 4,422 bp for S. Typhimurium strains (HS5344, HS5437, and HS5478) and (HS5302 and HS5368), respectively. Genomic analysis for antimicrobial resistome confirmed the presence of clinically important genes, including blaCARB-2, aac(6')-Iaa, aadA2b, sul1, tetG, floR, and biocide resistance genes (qacEΔ1). S. Typhimurium strains harbored IncFIB plasmid containing spvRABCD operon, as well as rck and pef virulence genes, which constitute an important apparatus for spreading the virulence plasmid. In addition, we identified several virulence genes, chromosomally located, while the phylogenetic analysis revealed clonal relatedness among these strains with S. enterica isolated from human and non-human sources obtained in European and Asian countries. Our results provide new insights into this unusual class 1 integron in virulent S. Typhimurium strains that harbors a pool of genes acting as potential hotspots for horizontal gene transfer providing readily adaptation to new surrounds, as well as being crucially required for virulence in vivo. Therefore, continuous genomic surveillance is an important tool for safeguarding human health.

Introduction

Non-typhoidal Salmonella (NTS) is one of the most important foodborne pathogens with unprecedented impact on global health [1]. Among NTS, Salmonella enterica subsp. enterica serovar Typhimurium represents a major threat, since its worldwide spread has been associated with a broad host range, which includes mostly humans and food-related sources [1, 2]. Besides that, the emergence of multidrug-resistant (MDR) S. enterica is another crucial aspect for food-related outbreaks globally, limiting our therapeutic options [3].

In addition to the high global burden of salmonellosis, extended-spectrum β-lactamase (ESBL)-producing S. enterica strains have been recognized as high-priority bacteria causing serious public health issue (https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed). Aside from this, the emergence of mobile genetic elements (MGEs), for instance, class 1 integrons play an essential role in the global spread of antimicrobial resistance [4, 5]. Another aspect to be considered is the wide range of virulence package that is typically associated with Salmonella Pathogenicity Islands (SPI), contributing to the infection process among diverse hosts [6-8]. In this context, while the surveys with genomic approach have helped in the development of mitigation strategies and clinical management, continuous active surveillance is urgently required.

Here, we describe the genomic characteristics of five MDR and virulent S. Typhimurium strains carrying the blaCARB-2 gene recovered from clinical human stool samples in North Carolina, United States.

Materials and methods

Ethics approval and consent to participate

The human patients from whom Salmonella were recovered were completely anonymous and even after all the analysis and tests, the human sample remained anonymous. As such, the NC State IRB (FWA: 00003429) indicated the study research did not need IRB approval because it does not meet the definition for human subjects research.

Bacterial strains and antimicrobial susceptibility testing

We conducted a genomic investigation on five clinical S. Typhimurium strains collected in 2014 in North Carolina, United States. The strains were subjected to phenotypic characterization using the microdilution panel susceptibility approach on Gram-negative Sensititre plates (CMV3AGNF and GNX2F, Trek Diagnostic Systems, OH, USA) following the interpretative criteria of Clinical and Laboratory Standards Institute [9, 10]. The MDR profile was defined as resistant to three or more classes of antimicrobials [11]. All S. Typhimurium strains underwent molecular screening for class 1 integron by PCR [12, 13] and were subsequently characterized by whole-genome sequencing (WGS) according to Pornsukarom et al. [14].

Whole-genome sequencing and phylogenetic analysis

Libraries were prepared using the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA), which were multiplexed and sequenced on MiSeq platform (Illumina, San Diego, CA, USA) at a paired-end read (300 bp). Resulted raw sequence reads underwent a strict quality control, as well as we obtained the draft genomes by using default settings in CLC workbench 10.1.1 (Qiagen) as per Monte et al. [15]. The sequencing data were deposited in NCBI (PRJNA613764). For each strain, we uploaded the sequences into Center for Genomic Epidemiology (http://genomicepidemiology.org/) to detect multilocus sequence typing (MLST), resistome, plasmid incompatibility groups and Salmonella Pathogenicity Islands.

Virulome analyzes were performed by using default settings available in VFanalyzer [16]. Additionally, the genetic context of blaCARB-2 and presence of virulence genes were investigated using BLASTn analysis against the non-redundant (NR) database and manually curated using Geneious v. 11.1.5 (Biomatters Ltd., Auckland, New Zealand).

For phylogenetic purpose, we reconstructed a maximum likelihood phylogenetic tree based on single nucleotide polymorphism (SNP) using default settings of CSI Phylogeny version 1.4 [17]. SNP tree was reconstructed with five genomes of S. Typhimurium from this study in addition to thirteen genomes retrieved from GenBank database. Additional genomes of S. enterica strains were chosen from different sources (human, camel, food, poultry, ovine, river, and dog) and countries, including USA (SAMN10863500 and SAMEA6514930), France (SAMN07734943), Scotland (SAMEA773504 and SAMEA773551), Denmark (SAMEA4349586), Ireland (SAMEA4825483), Switzerland (SAMN08936646), Germany (SAMEA6058372), Chile (SAMN14336901), China (SAMN09759463 and SAMN02844307), and Ethiopia (SAMN03577126).

Results

Antimicrobial susceptibility testing and class 1 integron detection

All the five strains were classified as MDR, displaying resistance to critically important antimicrobials including ampicillin (100%), ticarcillin/clavulanic acid (100%), and streptomycin (60%), as well as to highly important antimicrobials comprising sulfisoxazole (100%), chloramphenicol (100%), and tetracycline (60%) (Table 1). Moreover, intermediate resistance to doxycycline was detected in three strains (HS5344, HS5437 and HS5478), and in a single strain (HS5437) to ceftazidime. In addition, we confirmed the presence of class 1 integron in all S. Typhimurium strains.

Table 1

Phenotypic and genomic features of Salmonella Typhimurium ST19 strains isolated from clinical human samples in United States.

Strain ID	Serotype	Source	R-type (MIC)*	Resistance genotype	Plasmids	ST	Accession number
HS5302	Typhimurium (O5-)	Stool	FIS-AMP-TIM2	blaCARB-2, aac(6’)-Iaa, sul1	IncFIB(S), IncFII(S)	19	JAATJP000000000
HS5344	Typhimurium (O5-)	Stool	CHL-TET-FIS-AMP-STR-TIM2	blaCARB-2, aac(6’)-Iaa, aadA2b, sul1, tet(G), floR	IncFIB(S), IncFII(S)	19	JAATGY000000000
HS5368	Typhimurium (O5-)	Stool	FIS-AMP-TIM2	blaCARB-2, aac(6’)-Iaa, sul1	IncFIB(S), IncFII(S)	19	JAATJO000000000
HS5437	Typhimurium (O5-)	Stool	CHL-TET-FIS-AMP-STR-TIM2	blaCARB-2, aac(6’)-Iaa, aadA2b, sul1, tet(G), floR	IncFIB(S), IncFII(S)	19	JAATGZ000000000
HS5478	Typhimurium	Stool	CHL-TET-FIS-AMP-STR-TIM2	blaCARB-2, aac(6’)-Iaa, aadA2b, aph(3’)-Ia, sul1, tet(G), floR	IncFIB(S), IncFII(S)	19	JAATHA000000000

*FIS, sulfisoxazole; AMP, ampicillin; TIM2, ticarcillin/clavulanic acid constant 2; CHL, chloramphenicol; TET, tetracycline; STR, streptomycin.

Genomic analysis revealed that all five S. Typhimurium strains belonged to the international sequence type (ST) ST19, while antimicrobial resistome confirmed the presence of critically important genes, such as carbenicillinase [blaCARB-2], aminoglycosides [aac(6’)-Iaa and aadA2b], sulfonamide [sul1], tetracycline [tetG], and florfenicol [floR]. The IncFIB(S) and IncFII(S) plasmid incompatibility groups were detected in all strains. We were also able to describe two schematic representations of the genetic context surrounding blaCARB-2 gene. First, three S. Typhimurium strains (HS5344, HS5437, and HS5478) analyzed in this study, shared a genomic environment with 4,062 bp in size composed by groEL/intI1-blaCARB-2-qacEΔ1-sul1-orf5 (acetyltransferase)-orf6 (hypothetical protein). Second, the remaining S. Typhimurium strains (HS5302 and HS5368) presented a genomic content slightly different with a 4,422 bp region composed by intI1-blaCARB-2-qacEΔ1-sul1-orf5 (acetyltransferase)-orf6 (hypothetical protein) (Fig 1). Additionally, the sul1, blaCARB-2, tetG, floR, and aadA2b resistance genes were harbored by a partial sequence of a complex class 1 integron (In104) from HS5344, HS5437, and HS5478. This sequence included duplications of parts of the integron conserved segments (CS), specifically, part of the intI1 gene from the 5’-CS and part of the 3’-CS (qacEΔ1 and partial sul1 genes). Consequently, the structure had two attI1 sites, into which the aadA2b gene cassette was inserted in one and the blaCARB-2 cassette in the other. The floR and tetG genes were identified between the two integron-derived regions. In HS5302 and HS5368, only the region containing the intI1-blaCARB-2-qacEΔ1-sul1-orf5-orf6 array was detected. Furthermore, while aac(6’)-Iaa was found at a site distant from the other resistance genes on the chromosome of all S. Typhimurium strains in this study, aph(3’)-Ia was identified in a partial transposon sequence from HS5478.

Fig 1

Schematic representation of the genetic context surrounding blaCARB-2 genes in Salmonella Typhimurium ST19 strains isolated from clinical human samples in United States.

Virulome analysis revealed presence of several Salmonella Pathogenicity Island (SPI-1, SPI-2, SPI-3, SPI-4, SPI-5, SPI-13, SPI-14, and Centisome 63 Pathogenicity Island) as shown in Table 2. Upon encountering these SPI, we also identified important virulence genes involved in fimbrial adherence (fimA, C, D, F, H, I, W, Y, Z), non-fimbrial adherence (misL), invasion (InvA, B, C, E, F, G, H, I, J), secretion system (ssa, ssc, sse, and ssr), magnesium uptake (mgtB and mgtC), regulation (phoP, phoQ, and pipB), and translocated effector (sopB/sigD and sopE2) (Table 2).

Table 2

Genomic features of virulence factors of Salmonella Typhimurium ST19 strains isolated from clinical human samples in United States.

Strain ID	SPI-1 encode genes	SPI-2 encode genes*	SPI-3 encode genes	SPI-5 encode genes	Virulence plasmid*	Fimbrial adherence determinants	SPI*
HS5302	inv (A, B, C, E, F, G, H, I, J); sopE2	ssa (C, D, E, G, H, I, J, K, L, M, N, O, P, Q, R, T, U, V); ssc (A, B); sse (B, C, D, E); ssr (A, B)	mgtB, mgtC, misL	phoP, phoQ, pipB, sopB/sigD	spv (A, B, D, R)	fim (A, C, D, F, H, I, W, Y, Z)	SPI-1, SPI-2, SPI-3, SPI-5, SPI-13, SPI-14, C63PI
HS5344	inv (A, B, C, E, F, G, H, I, J); sopE2	ssa (C, D, E, G, H, J, K, L, M, N, O, P, Q, R, T, U, V); ssc (A, B); sse (B, C, D, E); ssr (A, B)	mgtB, mgtC, misL	phoP, phoQ, pipB, sopB/sigD	spv (A, B, D, R)	fim (A, C, D, F, H, I, W, Y, Z)	SPI-1, SPI-2, SPI-3, SPI-4, SPI-5, SPI-13, SPI-14, C63PI
HS5368	inv (A, B, C, E, F, G, H, I, J); sopE2	ssa (C, D, E, G, H, I, J, K, L, M, N, O, P, Q, R, T, U, V); ssc (A, B); sse (B, C, D, E); ssr (A, B)	mgtB, mgtC, misL	phoP, phoQ, pipB, sopB/sigD	spv (A, B, D, R)	fim (A, C, D, F, H, I, W, Y, Z)	SPI-1, SPI-2, SPI-3, SPI-4, SPI-5, SPI-13, SPI-14, C63PI
HS5437	inv (A, B, C, E, F, G, H, I, J); sopE2	ssa (C, D, E, G, H, I, J, K, L, M, N, O, P, Q, R, T, U, V); ssc (A, B); sse (B, C, D, E); ssr (A, B)	mgtB, mgtC, misL	phoP, phoQ, pipB, sopB/sigD	spv (A, B, D, R)	fim (A, C, D, F, H, I, W, Y, Z)	SPI-1, SPI-2, SPI-3, SPI-4, SPI-5, SPI-13, SPI-14, C63PI
HS5478	inv (A, B, C, E, F, G, H, I, J); sopE2	ssa (C, D, E, G, H, J, K, L, M, N, O, P, Q, R, T, U, V); ssc (A, B); sse (B, C, D, E); ssr (A, B)	mgtB, mgtC, misL	phoP, phoQ, pipB, sopB/sigD	spv (A, B, D, R)	fim (A, C, D, F, H, I, W, Y, Z)	SPI-1, SPI-2, SPI-3, SPI-5, SPI-13, SPI-14, C63PI

*Letters highlighted in bold represents differences among strains.

Interestingly, these strains possess a highly conserved spv operon composed by spvR, spvA, spvB, spvC, and spvD genes which are located upstream of the genes pefA (plasmid-encoded fimbriae) and rck (resistance to complement killing) in a virulence plasmid as shown in Fig 2. In addition, in silico analyses confirmed that these virulence genes were located on IncFIB plasmid.

Fig 2

Genomic comparison between genetic contexts of virulence plasmids carried by Salmonella Typhimurium strains from this study (A) and S. enterica strains B (CP000858), C (NC_002638), and D (AY517905) as out-group.

Genes and shotgun sequences were retrieved from the GenBank database. Arrows indicate the positions and directions of the genes; Regions with >99% identity are indicated with gray shading.

To achieve a better understanding of the clonal spread of these MDR strains, we reconstructed a phylogenetic tree based on SNPs. Indeed, these strains were found to be genetically related. The phylogenetic tree framed a major cluster composed by five S. Typhimurium strains from this study (HS5478, HS5344, HS5437, HS5302, and HS5368), which nested together with S. enterica strains from different sources (Human, poultry, ovine) and countries, including Denmark (SAMEA4349586), Scotland (SAMEA773504 and SAMEA773551), France (SAMN07734943), and China (SAMN09759463) as shown in Fig 3. Interestingly, S. Typhimurium strains within same cluster shared the same resistance phenotype and genotype profile.

Fig 3

SNP-based phylogenetic tree composed by five Salmonella Typhimurium and additional 14 Salmonella enterica strains.

This figure was generated with iTOL v.5.5 (https://itol.embl.de).

Discussion

The continuous dispersal of MDR S. enterica strains frequently deserves attention of the public health authorities, particularly the international lineages as S. Typhimurium ST19 that most often causes diseases and deaths [18, 19]. Owing to their importance, the ST19 members have been globally identified in a variety of sources, such as human clinical samples, animals, food products, and environmental samples [20-22]. Moreover, S. Typhimurium ST19 has shown broad resistance to a variety of critically important antimicrobials [23], including colistin (an antibiotic of last resort for some MDR infections) [24, 25]. Besides that, the occurrence of intermediate resistance reported here implies in possible treatment failure that should be noted by public health authorities.

It is important to note that these strains can easily acquire such genes through mobile genetic elements such as plasmids, integrons, and genomic islands from other MDR clones, resulting in their rapid dissemination. The presence of class 1 integron in all S. Typhimurium ST19 strains constitutes a risk factor to the rapid spread of antimicrobial resistance (AMR) genes. Indeed, class 1 integron coding various resistance profiles has been widely reported in S. Typhimurium as well as in multiple serovars [5, 21, 26–30]. This genetic frame is crucial for the spread resistance markers, since they are able to capture AMR genes through chromosomal cassettes incorporating them by site-specific recombination [4, 12, 31]. Additionally, resistance genes located in class 1 integrons are often within Salmonella genomic islands (SGI), such as the conjugative Salmonella genomic island 1 (SGI1) (~43-kb) and its variants [32, 33].

The detection of quaternary ammonium compounds (QACs) raises a particular concern, since this qac-containing integrons typically harbors a pool of genes that are hotspots for horizontal gene transfer providing readily adaptation to new surrounds [34, 35]. The co-resistance of critically important antimicrobials and disinfectants QACs reinforces the evidence of the overuse of biocides in clinical settings [34], and their spread have been also described in Salmonella serotypes isolated from livestock [36].

The blaCARB-2 gene, earlier identified as blaPSE-1, is most often a part of the chromosomal cassette [37, 38]. To date, the occurrence of this carbenicillinase gene has been limited to a few reports in different bacteria species and countries, including Acinetobacter pittii and Salmonella serovars in Australia [38, 39], Salmonella Typhimurium from England and Wales [40], Salmonella Senftenberg in Mexico [41], S. Typhimurium in Canada [42], Pseudomonas aeruginosa in Netherlands [43], and Escherichia coli in Pakistan [44]. It is noteworthy that such genetic element has the ability to move among different lineages of S. enterica serovars on a global scale, contributing to AMR spread [28]. Indeed, the genetic contexts surrounding blaCARB-2 gene in this study are typically found in SGI1 and its variant SGI1-B.

Drug-resistant variants of SGI1 have been identified in numerous S. enterica serovars, and strains harboring them may be more virulent and have a tendency to rapidly disseminate [33, 39]. In fact, S. Typhimurium strains within this survey demonstrate to possess several virulence factors, which have been reported earlier [45-48]. Furthermore, we confirmed the presence of several plasmid-borne virulence genes (spvR, spvA, spvB, spvC, spvD, rck, and pefA) that denotes an important genomic apparatus for the spreading of this plasmid, and may provide fitness benefit as previously reported [28, 49, 50]. Increasing evidences have demonstrated that the spv operon affects the formation of autophagosomes, as well as highlight its association in killing of macrophages and neutrophils [6], being crucially required for virulence in vivo [8], including aggravated damage in zebrafish infection model [7]. Furthermore, the PhoP-regulated gene mig-14 that is required for virulence and resistance to antimicrobial peptides was detected in these strains. Yet, mig-14 contributes to Salmonella persistence in hosts, being also associated with resistance against polymyxin B and cathelin-related antimicrobial peptide (CRAMP) [51-54]. Thus, the clonal dissemination of MDR S. Typhimurium (mostly the invasive clones) constitutes an important issue to public health [55], especially S. Typhimurium ST19, which have been circulating worldwide (http://enterobase.warwick.ac.uk/) as demonstrated in this study, since our S. Typhimurium strains nested with international lineages from at least four countries (Fig 2).

In summary, we report the genomic features of virulent and MDR S. Typhimurium ST19 strains carrying the blaCARB-2 gene recovered from clinical human samples in United States. Our results provide new insights into this genetic environment that besides blaCARB-2, contains genes, coding resistance to quaternary ammonium compounds (qacEΔ1) and sulfonamides (sul1). Furthermore, our findings could aid in understanding the epidemiology of S. Typhimurium ST19, which are of great value to initiate preventive measures to safeguard human health. Given the high spread of this international lineage, especially among the young and the elderly or immunocompromised people, public health authorities and regulatory food agencies need to be aware of the potential impact in public health and in economy caused by such pandemic MDR S. Typhimurium ST19 lineage, with particular attention in high-burden areas.

3 Sep 2020

PONE-D-20-21578

Class 1 Integron-Borne Cassettes harboring blaCARB-2 gene in Multidrug-Resistant Salmonella Typhimurium ST19 Strains recovered from clinical human stool samples, United States

PLOS ONE

Dear Dr. Thakur,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Reviewer comments on the manuscript need to be addressed.

==============================

Please submit your revised manuscript by Oct 18 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Additional Editor Comments (if provided):

The reviewer comments available on the manuscript. These need to be addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) (Limit 200 to 20000 Characters)

Could you please see my attached review, I have added all my comments to the Author in an attachment.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Submitted filename: Salmonella ST19.docx

Click here for additional data file.

2 Oct 2020

Response to reviewers, Manuscript PONE-D-20-21578.R1

Line numbers in our response refer to the line numbers in the revised manuscript (marked-up).

General comments:

We sincerely appreciate the editorial board and reviewers for their careful review and constructive suggestions. It is our belief that the manuscript was substantially improved after making the suggested edits. We have responded to specific queries below.

Comments from Reviewers:

Reviewer #1:

This manuscript describes about the class 1 integron AMR cassettes harboring blaCARB-2 gene in MDR Salmonella Typhimurium ST19 isolates. These MDR isolates are also harbored several virulence encoding genes and SPIs.

Response: We sincerely thank the reviewer for the favorable comments.

Comments:

Based on the WHO’s description, some of the antimicrobial such as ticarcillin/clavulanic acid and tetracycline are not critically and highly important antimicrobials.

Response: We appreciate your suggestion. However, based on this document: Critically important antimicrobials for human medicine, 6th revision. Geneva: World Health Organization; 2019. https://apps.who.int/iris/bitstream/handle/10665/312266/9789241515528-eng.pdf?sequence=1&isAllowed=y, we could observe that ticarcillin/clavulanic acid and tetracycline are classified as critically and highly important antimicrobials.

Lines 69-70. ‘CARB-2-production’ was not tested in these S. Typhimurium isolates, but only the encoding gene was detected.

Response: We agree. This has been deleted in lines 72 and 245.

Line 75. It will be useful if the nature of clinical source (watery diarrhea, diarrhea with mucus or dysentery-like stool) of the isolates and clinical history of the patients described and included. In addition, the year/location of isolation is also important to be mentioned in the text to deduce whether the isolates are spread all over the country or restricted to a certain geographical location.

Response: We fully agree. At the beginning of this study, we tried to collect such information to conduct the paper describing the clinical history of the patients. In our understanding, such information could aid to mitigate strategies, as well as give to readers a full background, which denotes the real threat of salmonellosis and their impacts in human health. However, we did not get permission from Public Health Laboratory due to health information privacy to publish this information. Therefore, we respectfully request that the paper be published with the information provided.

Lines 100-101. What is the rational for selecting only 13 sequences for comparison? There other STs (e.g., ST39) that expresses more AMR than the ST19. It will be interesting to consider all the MDR S. Typhimurium STs from different sources.

Response: Our intention was to cover several countries (n=10) and sources (n=7) in this phylogeny by using S. enterica strains harboring blaCARB-2 gene, with exception of two strains that were used as out-groups.

Lines 114-115. It is not surprising, as these intermediate 
resistant isolates to doxycycline are also resistant to tetracycline. Doxycycline is a synthetic antibiotic derived from tetracycline.

Response: We agree. This has been modified in lines 117-119.

“Moreover, intermediate resistance to doxycycline was detected in three strains (HS5344, HS5437 and HS5478), and in a single isolate (HS5437) to ceftazidime”.

Lines 146-151. It will be interesting to compare these putative virulence encoding genes and SPIs with the infection status of the patients (pl refer comment #3).

Response: We agree. However, as prior mentioned, we are unable to provide this information.

The title of the manuscript reflects only the MDR part, but not about the virulence.

Response: We agree. The title has been modified. “Class 1 Integron-Borne Cassettes harboring blaCARB-2 gene in Multidrug-Resistant and Virulent Salmonella Typhimurium ST19 Strains recovered from clinical human stool samples, United States”. (Lines 2-4).

There is inconsistency while using the terms isolate and strain.

Response: Thank you for this observation. Since the main target of this study was the genomic investigation and all Salmonella Typhimurium were accessed from a collection, we believe that the term strain is the most appropriate. Therefore, we have replaced these terms throughout the manuscript in lines 31, 33, 72, 76, 77, 78, 83, 114, 118, 120, 126, 163, 176, 237, and 245.

Only the blaCARB-2 
was mapped in the class 1 integron. Are the other genes (aac(6’)-Iaa, aadA2b, aph(3’)-Ia, sul1, tetG, floR,) are located in the same AMR cassettes in the integron? How they are arranged on the chromosome?

Response: This information was added to the revised version of the manuscript. Lines 137-147: “Additionally, the sul1, blaCARB-2, tetG, floR, and aadA2b resistance genes were harbored by a partial sequence of a complex class 1 integron (In104) from HS5344, HS5437, and HS5478. This sequence included duplications of parts of the integron conserved segments (CS), specifically, part of the intI1 gene from the 5’-CS and part of the 3’-CS (qacE∆1 and partial sul1 genes). Consequently, the structure had two attI1 sites, into which the aadA2b gene cassette was inserted in one and the blaCARB-2 cassette in the other. The floR and tetG genes were identified between the two integron-derived regions. In HS5302 and HS5368, only the region containing the intI1-blaCARB-2-qacE∆1-sul1-orf5-orf6 array was detected. Furthermore, while aac(6’)-Iaa was found at a site distant from the other resistance genes on the chromosome of all S. Typhimurium strains in this study, aph(3’)-Ia was identified in a partial transposon sequence from HS5478.”

Submitted filename: R1_Response to reviewers_PONE-D-20-21578_DM-Sid.docx

Click here for additional data file.

7 Oct 2020

Class 1 Integron-Borne Cassettes harboring blaCARB-2 gene in Multidrug-Resistant and Virulent Salmonella Typhimurium ST19 Strains recovered from clinical human stool samples, United States

PONE-D-20-21578R1

Dear Dr. Thakur,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

All reviewer comments addressed satisfactorily.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The questions above (1-5) are addressed adequately. I do not have any comments to the authors in this revised version.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

14 Oct 2020

PONE-D-20-21578R1

Class 1 Integron-Borne Cassettes harboring blaCARB-2 gene in Multidrug-Resistant and Virulent Salmonella Typhimurium ST19 Strains recovered from clinical human stool samples, United States

Dear Dr. Thakur:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Iddya Karunasagar

Academic Editor

PLOS ONE